Delivery Order SPE2DB22D1017-SPE2DB24FF2HS
Award Date 2/5/24
Potential Completion Date 2/6/24
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $18,726.20 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the supply of 4,563,415,015 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine, with a period of performance through January 24, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,451.67 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,560,956,103 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,492.75 firm-fixed-price delivery order is for the supply of 4560616540 TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The award has an ultimate completion date of April 18, 2023. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccines. The contract has a ceiling value of $29,025.61 and an ultimate completion date of January 19, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support...
- This federal contract award, valued at $37,481.36, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order for the supply of the vaccine TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $7,964.76, is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccines to support military healthcare programs. This is a Firm Fixed Price Delivery Order with a completion date of January 19, 2024. The contract was awarded on January 18, 2024 and was not set aside for any specific...
- This federal contract award, valued at $30,720.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccination product, with a completion date of February 29, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing structure, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical...
- This federal contract award, valued at $6,782.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, with an ultimate completion date of November 20, 2023. The contract is a Delivery Order under a Firm Fixed Price pricing arrangement, with no set-aside designation indicated. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,681.55 delivery order is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine, under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and...
- The U.S. Defense Logistics Agency (DLA) awarded a $37,452.40 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 25 mcg/0.5 ml vials of the TYPHIM VI vaccine. This delivery order contract has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA Troop Support Medical with a potential value of up to $999,999,999.00 through December...